© 2014-2023 Clarity Pharma Research LLC  |  All Rights Reserved​ Privacy Policy
To learn more about our services, contact

​​Pulmonology / infectious disease

Nontuberculous mycobacteria pulmonary disease  A variety of strains cause this rare infectious lung disease. We conducted 7-nation market sizing studies and have compared treatment patterns for NTMPD in the US, Europe, and Asia.

We captured detailed information about current treatment practices, patient characteristics and disease states, and other medications used as therapy, with the goal of helping the client to see where its product might fill gaps. We also have studied refractory populations and the burden of illness in several nations.

Findings on some of this research have been published in medical journals and at international medical conferences, as shown in the "Related Articles or Presentations" column on this page

We also have studied other lung-related conditions, including chronic obstructive pulmonary disease (COPD), asthma, sarcoidosis and forms of lung cancer.

Related Articles or Presentations

  • International Society for Pharmacoeconomics and Outcomes Research (ISPOR) conference, 2 poster presentations on findings from an economic burden of illness study of a rare infection in Europe and Canada Poster1;  Poster2
  • European Respiratory Journal, co-author, research letter on poor adherence to treatment guidelines for a rare pulmonary disease Abstract
  • ISPOR conference, retrospective observational study to capture economic burden evidence in a rare disease AbstractPoster
  • EphMRA, “Precedent and consequence research to undergird orphan reimbursement strategy – A multi-layered, non-traditional approach” Presentation
  • Japanese Respiratory Society, treatment patterns for a rare lung disease in EU5, Japan and US Abstract
  • European Respiratory Society, prevalence and incidence of a rare lung disease in Europe Abstract
  • European Respiratory Society, treatment patterns for rare disease in EU5, Japan and US Abstract
  • European Respiratory Journal, treatment patterns for a rare lung infection in Europe, US and Japan, and article on prevalence in Europe, co-written with international team of medical experts,  Abstract 1& 2
  • KIT 2014 (Congress for Infectious Diseases and Tropical Medicine), co-author, rare lung infection prevalence in Germany Abstract
  • Annals of the American Thoracic Society, US study of rare lung infection Abstract  
  • American Thoracic Society (ATS) International Conference, study of rare lung infection Abstract